BluGlass Opens Coherent Collaboration on Next-Generation GaN Laser Device

BluGlass Starts Coherent Device Feasibility Study

BluGlass Limited (ASX:BLG) has secured an early-stage collaboration with global photonics company Coherent Corp (NYSE: COHR) to co-develop a novel gallium nitride device, giving the Australian laser developer a technical relationship with a much larger industry participant.

Valued at approximately A$286,000, or US$200,000, the initial study is expected to run for three to five months. It will test whether BluGlass and Coherent’s proprietary processes can work together, with early discussions already covering device architectures, epitaxial structures and process integration.

Visible-Wavelength Lasers Target Scientific and Medical Uses

The companies intend to evaluate manufacturing techniques for high-performance visible-wavelength lasers aimed at demanding scientific instrumentation and medical applications. BluGlass is contributing its expertise in GaN epitaxial growth and semiconductor laser development, while Coherent brings photonics engineering, advanced manufacturing and commercialisation capabilities, according to the announcement.

That combination gives the project a potentially useful bridge from semiconductor development to end-market access. BluGlass describes the device architecture as novel and says the work could expand its GaN laser portfolio into high-value scientific and medical markets, but the filing does not identify a final product, customer, expected volumes or revenue outcome.

Technical Milestones Will Determine the Next Step

The immediate test is compatibility between the two companies’ processes. A successful feasibility phase could lead to further development or commercial discussions, but the current agreement itself stops short of confirming a supply arrangement, manufacturing programme or product launch.

For BluGlass, the next meaningful signals will be the study’s technical outcome and whether the collaboration progresses beyond evaluation. Until then, the A$286,000 engagement is best viewed as a defined technical opportunity rather than evidence of recurring revenue or a completed commercial win.